373 related articles for article (PubMed ID: 15613554)
21. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
[TBL] [Abstract][Full Text] [Related]
22. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
23. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients.
Yonemura Y; Kinoshita K; Fujimura T; Fushida S; Sawa T; Matsuki N; Tanaka S; Kamata T; Takashima T; Miyazaki I
Hepatogastroenterology; 1996; 43(11):1260-72. PubMed ID: 8908561
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of treatment for synchronous hepatic metastases from gastric cancer with special reference to long-term survivors.
Kunieda K; Saji S; Sugiyama Y; Osada S; Sano J; Nagao N; Takahashi T; Takagi Y; Arai Y
Surg Today; 2002; 32(7):587-93. PubMed ID: 12111514
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors of gastric cancer tumours of less than 2 cm in diameter: rationale for limited surgery.
Yokota T; Kunii Y; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi H; Takahashi M; Kikuchi S; Yamauchi H
Eur J Surg Oncol; 2002 Apr; 28(3):209-13. PubMed ID: 11944951
[TBL] [Abstract][Full Text] [Related]
26. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
[TBL] [Abstract][Full Text] [Related]
28. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
29. [Neoadjuvant chemotherapy for advanced gastric cancer with para-aortic lymph node metastasis].
Uehara S; Murabayashi K; Kusta T; Takahashi K; Ogawa T; Onishi H; Saegusa S; Noda N; Okanami Y; Nakamura I
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1413-8. PubMed ID: 11681249
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of 68 patients with primary gastric lymphoma].
Luo ZG; Feng FY; Zhang P; Wang XY; Wang QL
Ai Zheng; 2004 Dec; 23(12):1692-5. PubMed ID: 15601562
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of positive lymph node ratio in gastric carcinoma.
Celen O; Yildirim E; Berberoglu U
J Surg Oncol; 2007 Aug; 96(2):95-101. PubMed ID: 17443727
[TBL] [Abstract][Full Text] [Related]
33. Impact of palliative gastrectomy in patients with incurable advanced gastric cancer.
Kunisaki C; Makino H; Takagawa R; Oshima T; Nagano Y; Fujii S; Otsuka Y; Akiyama H; Ono HA; Kosaka T; Ichikawa Y; Shimada H
Anticancer Res; 2008; 28(2B):1309-15. PubMed ID: 18505071
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
35. Gastric carcinoma: curative resection and adjuvant chemotherapy.
Carrillo Hernández JF; Ernesto de Obaldía Castillo G; Ramírez Ortega C; Frías Mendivil M; Pardo M
Arch Med Res; 1994; 25(1):29-35. PubMed ID: 8019111
[TBL] [Abstract][Full Text] [Related]
36. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma.
Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Br J Cancer; 1999 Oct; 81(3):484-9. PubMed ID: 10507774
[TBL] [Abstract][Full Text] [Related]
37. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
[TBL] [Abstract][Full Text] [Related]
38. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
